|
HY-47228-50mg
|
MedChemexpress LLC
|
KB-5492 (free base) [CAS 113594-64-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-47228-1mL
|
MedChemexpress LLC
|
KB-5492 (free base) [CAS 113594-64-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-19519-10mg
|
MedChemexpress LLC
|
Ladarixin [CAS 849776-05-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-19519-25mg
|
MedChemexpress LLC
|
Ladarixin [CAS 849776-05-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-19519-5mg
|
MedChemexpress LLC
|
Ladarixin [CAS 849776-05-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-19519-1mL
|
MedChemexpress LLC
|
Ladarixin [CAS 849776-05-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-P99110-1mg
|
MedChemexpress LLC
|
Lanadelumab [CAS 1426055-14-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99110-10mg
|
MedChemexpress LLC
|
Lanadelumab [CAS 1426055-14-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99110-5mg
|
MedChemexpress LLC
|
Lanadelumab [CAS 1426055-14-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-Y0366-1g
|
MedChemexpress LLC
|
Lauric acid [CAS 143-07-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-Y0366-500mg
|
MedChemexpress LLC
|
Lauric acid [CAS 143-07-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-Y0366-1mL
|
MedChemexpress LLC
|
Lauric acid [CAS 143-07-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-Y0366S-250mg
|
MedChemexpress LLC
|
Lauric acid-13C [CAS 93639-08-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-Y0366S1-100mg
|
MedChemexpress LLC
|
Lauric acid-d23 [CAS 59154-43-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-Y0366S1-25mg
|
MedChemexpress LLC
|
Lauric acid-d23 [CAS 59154-43-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-Y0366S1-50mg
|
MedChemexpress LLC
|
Lauric acid-d23 [CAS 59154-43-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-Y0366S3-1mg
|
MedChemexpress LLC
|
Lauric acid-d3 [CAS 79050-22-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-Y0366S3-10mg
|
MedChemexpress LLC
|
Lauric acid-d3 [CAS 79050-22-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-Y0366S3-5mg
|
MedChemexpress LLC
|
Lauric acid-d3 [CAS 79050-22-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-14270-10mg
|
MedChemexpress LLC
|
Lodoxamide [CAS 53882-12-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-14270-100mg
|
MedChemexpress LLC
|
Lodoxamide [CAS 53882-12-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-14270-200mg
|
MedChemexpress LLC
|
Lodoxamide [CAS 53882-12-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-14270-5mg
|
MedChemexpress LLC
|
Lodoxamide [CAS 53882-12-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-14270-50mg
|
MedChemexpress LLC
|
Lodoxamide [CAS 53882-12-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-14270-1mL
|
MedChemexpress LLC
|
Lodoxamide [CAS 53882-12-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
